ALK and anaplastic large cell lymphoma: A recent clinical study conducted by the MD Anderson Cancer Center of 95 patients with ALCL showed that the positive rate of PD-L1 in ALK+ ALCL patients is higher than that in ALK- cases (76% and 42%, respectively) (42).